Immunotherapy in urothelial cancer, part 1: T-cell checkpoint inhibition in advanced or metastatic disease
/in International Publications, Newcastle Disease Virus, Urothelial Carcinoma /von 2017-06-01 / Clin Adv Hematol Oncol 2017 Jun;15(6):466-477Prospect of Immunotherapy for Glioblastoma: Tumor Vaccine, Immune Checkpoint Inhibitors and Combination Therapy
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2017-05-24 / Neurol. Med. Chir. (Tokyo) 2017 Jul;57(7):321-330Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy
/in International Publications, Newcastle Disease Virus /von 2017-05-23 / Cancer Res. 2017 08;77(15):4146-4157Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2017-05-20 / Int J Mol Sci 2017 May;18(5)The Role of Radiofrequency Hyperthermia in The Radiosensitization of A Human Prostate Cancer Cell Line
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2017-05-17 / Cell J 2017;19(Suppl 1):86-95Enhanced DNA Damages of Human Prostate Cancer Cells Induced by Radiofrequency Capacitive Hyperthermia Pre- and Post X-rays: 6 MV versus 15 MV
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2017-05-17 / Cell J 2017;19(Suppl 1):79-85Immunotherapeutic approaches for hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2017-05-16 / Oncotarget 2017 05;8(20):33897-33910Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives
/in International Publications, Newcastle Disease Virus /von 2017-05-15 / Front Immunol 2017;8:555Trial watch: Dendritic cell-based anticancer immunotherapy
/in Dendritic Cells, International Publications /von 2017-05-12 / Oncoimmunology 2017;6(7):e1328341
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de